3M to invest nearly $150 million on expanding biopharma filtration capabilities
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
The investment will include facility and equipment improvements and the addition of 60 full-time positions in 3M manufacturing facilities in Europe.
Aim is to predict novel catalysts using machine learning (ML) and artificial intelligence (AI) techniques
One thousand times more soluble than L-cystine at neutral pH
Data support that antibiotic aztreonam-avibactam (ATM-AVI) is effective and well-tolerated in treating infections caused by Gram-negative bacteria, with a similar safety profile to aztreonam alone
Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology
This fresh infusion of capital will enable ImmunoACT to fast track the additional supply of the lead candidate HCAR-19
The US FDA in its communication mentioned it may withhold approval of any pending applications or supplements in which this facility is listed.
The project is part of a three-year-long partnership between Honeywell and Americares to strengthen the health infrastructure in rural Maharashtra, Uttarakhand and Haryana
The target boundary includes biogenic land?related emissions and removals from bioenergy feedstock
HMD had supplied 921.7 million syringes to the Government of India to facilitate over 2.2 billion Vaccination in India till date
Subscribe To Our Newsletter & Stay Updated